{"id":883658,"title":"Guidance on use of Imvamune in monkeypox outbreaks in Canada: NACI rapid response - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-01-13","captureTimestamp":"2026-01-13T00:15:02.782000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-imvamune-monkeypox.html","snippet":"NACI Rapid Response: Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in Canada This publication was published before November 28, 2022. Since then, the World Health Organization began using 'mpox' as the preferred term for monkeypox disease. Download…","rawSnapshotUrl":"/api/snapshots/raw/883658","browseUrl":"https://replay.healtharchive.ca/job-7/20260113001502/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-imvamune-monkeypox.html#ha_snapshot=883658","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}